Cargando…
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
BACKGROUND: Guidelines for primary prevention of cardiovascular diseases focus on prediction of coronary heart disease and stroke. We assessed whether or not measurement of N-terminal-pro-B-type natriuretic peptide (NT-proBNP) concentration could enable a more integrated approach than at present by...
Autor principal: | Natriuretic Peptides Studies Collaboration |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Lancet, Diabetes & Endocrinology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035346/ https://www.ncbi.nlm.nih.gov/pubmed/27599814 http://dx.doi.org/10.1016/S2213-8587(16)30196-6 |
Ejemplares similares
-
Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons
por: Daniels, Lori B.
Publicado: (2010) -
Natriuretic peptides in cardiovascular diseases
por: Piechota, Mariusz, et al.
Publicado: (2008) -
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
por: Collaborative Group on Epidemiological Studies of Ovarian Cancer
Publicado: (2015) -
Natriuretic Peptide and Cardiovascular Risk: Is It About “U”?
por: deFilippi, Christopher R, et al.
Publicado: (2015) -
Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)